about
Vincristine-induced peripheral neuropathy in pediatric cancer patientsNoninvasive peroneal sensory and motor nerve conduction recordings in the rabbit distal hindlimb: feasibility, variability and neuropathy measureNeostigmine for the treatment of acute colonic pseudo-obstruction (ACPO) in pediatric hematologic malignanciesAdverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health.Impairments that influence physical function among survivors of childhood cancerNeuropathic pain during treatment for childhood acute lymphoblastic leukemia.Adverse interactions between antifungal azoles and vincristine: review and analysis of cases.Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.Interrelationships of undernutrition and neurotoxicity: food for thought and research attention.Targeting gastrin-releasing peptide as a new approach to treat aggressive refractory neuroblastomas.Oxaliplatin-related neuropathy in Indian patients - no difference between generic and original molecules.Risk of azole-enhanced vincristine neurotoxicity in pediatric patients with hematological malignancies: old problem - new dilemma.Challenges Evaluating Chemotherapy-Induced Peripheral Neuropathy in Childhood Cancer Survivors.Impact of Undernutrition on the Pharmacokinetics and Pharmacodynamics of Anticancer Drugs: A Literature Review.Vincristine-induced neurotoxicity: electrophysiological features in children.T-acute lymphoblastic leukemia in a young adult complicated with unusual findings: an interesting case.Successful treatment of vincristine induced ptosis and polyneuropathy with pyridoxine and pyridostigmine in a child with acute lymphoblastic leukemia.Clinical Presentation of Inadvertent Intrathecal Vincristine Masquerading Guillain-Barre Syndrome.Vincristine-induced neuropathy in childhood ALL (acute lymphoblastic leukemia) survivors: prevalence and electrophysiological characteristics.Pharmacokinetics of liposomal-encapsulated and un-encapsulated vincristine after injection of liposomal vincristine sulfate in beagle dogs.Classical Hodgkin Lymphoma Presenting with Severe, Recurrent Hypothermic Episodes
P2860
Q28078232-D8DE3998-1BC0-4115-9D15-428E580B5D2DQ28541336-A150333B-6B8F-448A-BA0B-0B3980B33F49Q34316792-7A545F43-C16C-400B-B5DB-E045A2BD79BAQ35076156-C6621FBC-5EF0-4B87-A583-6D81838FCF7DQ35082766-54B354F2-F28B-4906-B289-CD9C39B9D568Q35106072-215A443E-E643-4EC5-89A4-B48727F5DAE1Q35936943-C31208CB-4D72-4251-8149-6B6A2EC8FED6Q36176588-46DA4CAF-D7AD-4A3D-96FE-03415F1F2170Q36222137-86E538AA-502E-4691-889A-7AC7AF8E85FCQ36890860-CD5A9C75-C48A-4441-B032-7027C2A59A86Q37584933-7DD9DDE4-DDD9-4BA3-916C-BD9C4984483DQ37832214-85A72EA7-DCDC-4D98-96C1-998DB21D320EQ38850862-ECB10926-C98D-488D-A8FD-DB4827C2AD5EQ38869469-82978789-371C-43D2-A7EC-08EEB0555406Q39818535-7DFFCCF1-A0E2-400F-A0E5-DC48EA9167EEQ40114086-C0A060D1-EF5B-4A8E-A175-41F17572E01BQ41902722-9BBE46CA-489F-40E6-9064-4B2E5BA1CA9FQ42150803-F2A5C8CC-680D-4287-AD99-BA6BB58856BEQ44301929-ED6F6625-F6CB-4525-BDE8-267AD12D2EE9Q44305714-8FE21B1E-A71F-4818-9CB7-6BB6F1CAC5FDQ57821426-E6E4C4E9-1C81-416F-AE67-074E44C9A546
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Vincristine induced neurotoxicity in cancer patients.
@en
Vincristine induced neurotoxicity in cancer patients.
@nl
type
label
Vincristine induced neurotoxicity in cancer patients.
@en
Vincristine induced neurotoxicity in cancer patients.
@nl
prefLabel
Vincristine induced neurotoxicity in cancer patients.
@en
Vincristine induced neurotoxicity in cancer patients.
@nl
P2093
P1476
Vincristine induced neurotoxicity in cancer patients.
@en
P2093
Devender Chhonker
Pooja Dewan
Sunil Gomber
P2888
P304
P356
10.1007/S12098-009-0254-3
P577
2010-01-01T00:00:00Z